NDC00085-0787-81: POTASSIUM CHLORIDE EXTENDED-RELE.
POTASSIUM CHLORIDE EXTENDED-RELE. Key specifications include special_features: 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS, features_provided: UNIT DOSE, primary_container_type: STRIP, therapeutic_equivalent: K-DUR BY KEY PHARMACEUTICALS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-266-8634, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS |
| features_provided | UNIT DOSE |
| primary_container_type | STRIP |
| therapeutic_equivalent | K-DUR BY KEY PHARMACEUTICALS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG |
| NSN | 6505-01-266-8634 |
| THERAPEUTIC EQUIVALENT | K-DUR BY KEY PHARMACEUTICALS |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | UNIT DOSE |
| PRIMARY CONTAINER TYPE | STRIP |
| SPECIAL FEATURES | 20 MEQ POTASSIUM EQUIVALENT; COMPRISED OF MICROENCAPSULATED CRYSTALS; 100 TABLETS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 100S PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1500.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |